4 stocks to watch on Friday: lululemon athletica, Papa John's and more
sshepard/iStock Unreleased via Getty Images
U.S. stock index futures on Friday were higher, after the latest nonfarm payrolls report showed a rise in the unemployment rate, adding onto earlier indicators this week that have showed a cooling in the labor market. The jobless rate ticked up to 3.8% in August from 3.5% in July. Markets on Thursday had ended August in the red. Here are some stocks to watch on Friday: 

lululemon athletica (NASDAQ:LULU) stock gained nearly 3% in pre-market trading, after the yoga wear maker showed strength in quarterly sales and delivered a rise in comparable sales at a time where rivals have reported a slowdown. LULU has seen solid demand for its apparel, partly based on a strong branding name. LULU's total Q2 comparable sales rose 11%, compared to a 3%, 5%, 7% and 11% fall for adidas (OTCQX:ADDYY), Under Armour (UA) (UAA), Victoria's Secret (VSCO) and Gap's (GPS) Athleta, respectively.
Class A shares of MongoDB (MDB) jumped nearly 5% ahead of the opening bell, after Wall Street saw the developer and database company's FQ2 2024 results and guidance as "generally positive." MDB's Atlas database saw significant growth in the quarter, with revenue for the segment rising 38% Y/Y and accounting for 63% of total revenue.
Shares of Papa John's International (PZZA) rose nearly 4% ahead of market open, after Wedbush said the stock was too cheap. The brokerage upgraded it to Outperform from Neutral, calling the stock's 16% discount to peers' median EV/'24 EBITDA multiple of 16.3x "unwarranted." Wedbush sees PZZA getting a revenue bump from improved speed of service, successful menu offerings and promotional activity, and an increase in customer traffic on weekends.
Horizon Therapeutics (HZNP) stock added almost 3% in pre-market trading, after the Federal Trade Commission said it had settled with healthcare giant and Dow 30 component Amgen (AMGN) over its planned $28B acquisition of HZNP. Shares of Amgen (AMGN) were also up 1.4% ahead of the opening bell. As per the settlement terms, AMGN agreed not to bundle its products with Horizon's (HZNP) drugs.

More on the markets

Biggest stock movers today: Dell Technologies, Broadcom and more
Commodity Roundup: Spot gold, oil poised for weekly gain; non-farm payroll report awaited
Appropriately Restrictive
Sentiment Speaks: These Stocks Can Potentially Double (Or More) Within The Next Few Years
The 'Big Short' Ignores Buffett And Bets Big On A Selloff: SPY Implications
Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q2 2023 Update